Inhibition of NF-kB traslocation to the nucleus Inhibition of tumor invasion suppressing miRNAs (miR-10b, miR-17, miR-21, miR-9) [18] Omega-3 EPA-FFA 2.5% or 5% treatment for 12 weeks in ApcMin/+ mice determines a 71% and 78% reduction in polyps number, respectively
[63]
EPA FFA 2g daily treatment for 6 months in FAP patients determines a 22% reduction in polyp number and a 29% reduction in sum of polyp diameters 5 years treatment with 5-ASA in UC-patients have no effect on dysplasia or on low grade dysplasia [102] Mesalamine treatment in IBD patients have no protective effect on neoplastic transformation [103] 5-ASA treatment for 12 months in IBD patients have no effect in neoplastic transformation [104, 105] Immunomodulators AZA/6-MP treatment in UC-patients have no effect on the development of neoplastic transformation in the colon [109] Thiopurine in IBD patients is associate with a significant decrease risk to develope advanced neoplasia [110] Omega-3 EPA-FFA treatment for 47 days in CAC mice determines a reduction in polyps incidence, multiplicity and size [112••] UDCA UDCA treatment in CAC/PCS patients determines a 10-40% reduction in cancer development [120, 121] UDCA treatment at high dose for long use in UC/PCS patients determines a 4 times increase risk to develop CRC [122] Curr Colorectal Cancer Rep (2017) 13:489-491 
